Peter Hotez


Baylor College of Medicine

Peter J. Hotez, M.D., Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine where he is also chief of a new Section of Pediatric Tropical Medicine and the Texas Children’s Hospital Endowed Chair of Tropical Pediatrics. He is the President of the Sabin Vaccine Institute.

Dr. Hotez is an internationally-recognized physician-scientist in neglected tropical diseases and vaccine development. He leads the only product development partnership for developing new vaccines for hookworm infection, schistosomiasis, and Chagas disease, diseases affecting hundreds of millions of children and adults worldwide. In 2006 at the Clinton Global Initiative he co-founded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for hundreds of millions of people

He obtained his undergraduate degree in molecular biophysics from Yale University in 1980 (phi beta kappa), followed by a Ph.D. degree in biochemical parasitology from Rockefeller University in 1986 and an M.D. from Weil Cornell Medical College in 1987.
Dr. Hotez has authored more than 300 original papers and is the author of the acclaimed Forgotten People, Forgotten Diseases (ASM Press).

Dr. Hotez served previously as President of the American Society of Tropical Medicine and Hygiene and founding Editor-in-Chief of PLoS Neglected Tropical Diseases. He is an elected member of the Institute of Medicine (IOM) of the National Academy of Sciences and in 2011 he was awarded the Abraham Horwitz Award for Excellence in Leadership in Inter-American Health by the Pan American Health Organization of the WHO.

In 2015 the White House and U.S. State Department selected Dr. Hotez as a United States Science Envoy.

From this contributor

Explore more from The Transmitter

Can AI do neuroscience without understanding?

Prediction without understanding sustained astronomy through a thousand years of epicycles. Artificial intelligence is now offering neuroscience the same deal.

By Anthony Zador
27 April 2026 | 6 min read
Hands cut a ribbon.

What Trump’s psychedelics executive order means for basic neuroscience

The order provides a potential path to remove some psychedelic drugs from the strictest regulatory category, yet it “may not be the breakthrough the basic research community has been looking for,” says neuroscientist Shawn Lockery.

By Calli McMurray
24 April 2026 | 4 min read
Research image visualizing neuronal activity.

Switching neural code may solve ongoing face-recognition debate

Face patch cells in macaque monkeys initially respond to images of any object but rapidly transition to attend to faces exclusively, a new study finds.

By Holly Barker
23 April 2026 | 5 min read